SCHOTT Group Secures Science‑Based Targets Validation, Boosting Decarbonisation Efforts Across Manufacturing

SCHOTT Group receives validation from the Science Based Targets initiative for its climate goals, confirming the targets meet the required methodology and criteria. The approval covers the company's overall emissions reduction plan across its manufacturing and research operations.

Science Based Targets initiative validates that SCHOTT’s emissions pathway aligns with the Paris Agreement limit of 1.5°C, requiring absolute reductions in scope 1, 2 and 3 emissions. The validation process involved third‑party assessment of data and target setting methodology.

SCHOTT Pharma announces a strengthened focus on decarbonisation, planning to invest in low‑carbon technologies and renewable energy for its production sites. The company expects the validated targets to guide future investments and reporting, supporting its role in the broader chemical industry transition.

Industry observers note that validation may encourage other chemical firms to adopt science‑based targets, potentially influencing policy and supply chain expectations.